Impact of HIV-1 genetic diversity in China on the measurement of viral load

被引:25
作者
Wang, Youchun [1 ]
Song, Aijing [1 ]
Xu, Sihong [1 ]
Li, Xiuhua [1 ]
Chong, Huihui [1 ]
Zhao, Chenyan [1 ]
Nie, Jianhui [1 ]
Zhang, Chuntao [1 ]
机构
[1] Natl Inst Control Pharmaceut & Biol Prod, Dept Cell Biol, Beijing 100050, Peoples R China
关键词
HIV-1; clade; amplicor HIV-1 monitor v1.5 test; nuclisens HIV-1 QT assay; NucliSens EasyQ HIV-1 assay;
D O I
10.1002/jmv.21048
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this study, 190 HIV-positive samples were collected from different regions of China. The HIV clades of 153 samples were determined successfully based on env sequencing. Specifically, 48, 5, 87, and 13 isolates belonged to clades B', B, BC, and AE, respectively. The viral loads in all samples were measured using three commercial assays, Amplicor HIV-1 monitor v1.5, Nuclisens HIV-1 QT and NucliSens EasyQ HIV-1 assays. The differences and linear correlations for individual assays were compared, with expected 1:1 relationships. Significant differences were found for the following viral loads: clade BC measured by any two assays (P < 0.001); clade AE between Amplicor 1.5 and Easy Q (P=0.005); clade B' between Amplicor 1.5 and Nuclisens QT (P= 0.002); clade AE between Amplicor 1.5 and Nuclisens QT (P=0.025); and clade B' between Amplicor 1.5 and EasyQ (P=0.04). The largest mean difference in the log(10) values was 0.9518, which was found between Amplicor 1.5 and Nuclisens QT. However, the viral loads for clades AE and B' measured by EasyQ and Nuclisens QT, and those for clade B measured by any two assays did not differ significantly. The degrees of correlation for clades B and B' between any two assays (13 > 0.8) were higher that those for clades AE and BC between any two assays (R < 0.7), except for clade AE between Amplicor 1.5 and Easy Q. Thus, the clade types, especially clades BC and AE, are most likely to impact on the quantitation of viral load using different-assays.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 27 条
[1]   Comparison of LCx with other current viral load assays for detecting and quantifying human immunodeficiency virus type 1 RNA in patients infected with the circulating recombinant form A/G (CRF02) [J].
Amendola, A ;
Bordi, L ;
Angeletti, C ;
Girardi, E ;
Ippolito, G ;
Capobianchi, MR .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (02) :811-815
[2]   Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02) [J].
Amendola, A ;
Bordi, L ;
Angeletti, C ;
Visco-Comandini, U ;
Abbate, I ;
Cappiello, G ;
Budabbus, MA ;
Eljhawi, OA ;
Mehabresh, MI ;
Girardi, E ;
Antinori, A ;
Ippolito, G ;
Capobianchi, MR .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (05) :488-494
[3]   Detection of HIV-1 subtype G using cobas ampliscreen test [J].
Araújo, FM ;
Henriques, IS ;
Monteiro, FP ;
Meireles, ER ;
Cunha-Ribeiro, LM .
JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (02) :205-206
[4]   Measuring agreement in method comparison studies [J].
Bland, JM ;
Altman, DG .
STATISTICAL METHODS IN MEDICAL RESEARCH, 1999, 8 (02) :135-160
[5]   Multisite comparison of reproducibility and recovery from the standard and ultrasensitive Roche AMPLICOR HIV-1 MONITOR assays [J].
Brambilla, DJ ;
Granger, S ;
Jennings, C ;
Bremer, JW .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :1121-1123
[6]   Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes [J].
Chew, CB ;
Herring, BL ;
Zheng, F ;
Browne, C ;
Saksena, NK ;
Cunningham, AL ;
Dwyer, DE .
JOURNAL OF CLINICAL VIROLOGY, 1999, 14 (02) :87-94
[7]   Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma [J].
de Mendoza, C ;
Alcamí, J ;
Sainz, M ;
Folgueira, D ;
Soriano, V .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) :1518-1521
[8]  
Elbeik T, 2002, J ACQ IMMUN DEF SYND, V29, P330
[9]  
FRAF M, 1998, AIDS RES HUM RETROV, V14, P285
[10]   Comprehensive comparison of the VERSANT® HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR® 1.5 assays on 1000 clinical specimens [J].
Galli, R ;
Merrick, L ;
Friesenhahn, M ;
Ziermann, R .
JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (04) :245-252